文章摘要

文章信息/Info

Title:: -

作者:: 白艳艳综述; 王长谦审校; 上海第二医科大学附属仁济医院心内科，上海 200001

Author(s):: -

关键词:: 冠状动脉疾病; 氯吡格雷; 氯吡格雷抵抗

Keywords:: -

分类号:: R541

DOI:: -

文献标识码:: A

摘要:: 氯吡格雷广泛用于急性冠脉综合征和经皮冠状动脉介入术的患者，可以减少心血管事件的发生，降低支架内亚急性血栓形成的发生率。但是临床上服用氯吡格雷的患者表现出各自不同的反应性，部分患者反应差甚至无反应，称之为氯吡格雷抵抗。本文就氯吡咯雷抵抗的定义、检测方法、机制及临床意义作一综述。

Abstract:: -

参考文献/References

［1］Clarke TA ,Waskell LA.The Metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin ［J］.Drug Metab Dispos，2003，31(1): 53-59.

［2］Quinn MJ, Bhatt DL, Zidar F，et al. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention［J］.Am J Cardiol,2004,93(6):679-684

［3］Nguyen TA, Diodati JG, Pharand C.Resistance to clopidogrel: A review of the evidence ［J］. J Am Coll Cardiol,2005,45(8):1157-1164

［4］Xiao Z,Therous P. Clopidogrel inhibits plateletleukocyte interactions and thrombin receptor agonist peptideinduced platelet activation in patients with an acute coronary syndrome ［J］ . J Am Coll Cardiol,2004,43(11):1982-1988

［5］Muller I, Besta F, Schulz C，et al. Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement ［J］. Thrombo Haemost,2003,89(5):783-787

［6］Geiger J,Teichmann L,Grossmann R，et al. Monitoring of clopidogrel action: comparison of methods ［J］. Clin Chem,2005,51(6):957-965.

［7］朱梅，贾庆良.氯吡格雷对不稳定型心绞痛患者血小板功能的影响［J］.心脏杂志,2003,15（5）:425-427.

［8］Lau WC, Waskell LA, Watkins PB, et al.Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug–drug interaction ［J］.Circulation,2003,107(1): 32-37.

［9］Fontana P,Dupont A, Gandrille S,et al .Adenosine diphosphate induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects ［J］.Circulation, 2003,108(8): 989- 995.

［10］Lau WC, Gurbel PA,Watkins PB, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of Clopidogrel resistance ［J］.Circulation, 2004, 109(2): 166- 171.

［11］ Lepantalo A, Virtanen KS, Heikkila J, et al.Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions［J］.Eur. Heart J,2004, 25(6): 476-483.

［12］Barragan P,Bouvier JL,Roquebert PO, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilatorstimulated phosphoprotein phosphorylation ［J］.Catheter Cardiovasc Interv ,2003,59(3):295-302.

［13］Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity ［J］.Circulation, 2003,107(23): 2908 - 2913.

［14］Matetzky S, Shenkman B, Guetta V,et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction ［J］. Circulation,2004,109(25): 3171–3175。

我们的网站为什么显示成这样？

氯吡格雷抵抗研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics